The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Docetaxel Kabi

80/4 milligram(s)/millilitre Concentrate for solution for infusion

Fresenius Kabi Deutschland GmbHEU/1/12/770/001

Main Information

Trade NameDocetaxel Kabi
Active SubstancesDocetaxel
Strength80/4 milligram(s)/millilitre
Dosage FormConcentrate for solution for infusion
Licence HolderFresenius Kabi Deutschland GmbH
Licence NumberEU/1/12/770/001

Group Information

ATC CodeL01CD Taxanes
L01CD02 docetaxel


Licence Issued22/05/2012
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceMedicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).
Marketing StatusMarketed


Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back